Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Tofacitinib may help regrow hair in alopecia areata patients.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

JAK inhibitors may help improve symptoms in adults with APECED.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Tjalma Syndrome is a rare condition in people with lupus, causing fluid buildup and high CA-125 levels, but not due to tumors.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Etanercept effectively treated a severe skin condition when other treatments failed.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Ixekizumab effectively treats generalized pustular psoriasis.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.